Live news related to IPSEN stock (FR0010259150): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Ipsen advances 4.55% to 133.30 euros this Wednesday, breaking through its resistance at 131.60 euros following the FDA's Breakthrough Therapy designat…
The U.S. regulator has awarded the 'Breakthrough Therapy' designation to Ipsen's IPN60340, an experimental monoclonal antibody for patients with acute…
The biopharmaceutical group unveiled 14 scientific communications on various movement disorders at the Madrid congress, according to the statement rel…
French laboratory Ipsen announced that the US Food and Drug Administration has granted 'Breakthrough Therapy' designation to its drug candidate IPN603…
The biopharmaceutical group Ipsen has released the data for the liquidity contract entrusted to Natixis Oddo BHF for the second half of 2025. As of De…
